Single-cell RNA sequencing reveals that TAF7 promotes colorectal cancer stemness by targeting SOX2.
7 affiliations
- 1Department of Tumor Surgery, The Affiliated Shaoyang Hospital of Traditional Chinese Medicine of Changsha Medical University, No. 631, Dongda Road, Shuangqing District, Shaoyang City, Hunan Province, 422000, China. [email protected].
- 2Department of Tumor Surgery, Shaoyang Hospital of TCM, Shaoyang City, Hunan Province, 422000, China. [email protected].
- 3Department of Clinical Laboratory, Shaoyang Hospital of TCM, Shaoyang City, Hunan Province, 422000, China.
- 4Department of Tumor Surgery, Shaoyang Hospital of TCM, Shaoyang City, Hunan Province, 422000, China.
- 5Department of Science and Education, Shaoyang Hospital of TCM, Shaoyang City, Hunan Province, 422000, China.
- 6Changsha Medical University, Changsha City, Hunan Province, 410219, China.
- 7Department of Hepatobiliary and Hernia Surgery, Anorectal, Second Affiliated Hospital of Shaoyang University, Shaoyang City, Hunan Province, 422000, China.
Abstract
Background
Cancer cell stemness plays a decisive role in tumor metastasis and recurrence. TATA-box binding protein-associated factor 7 (TAF7), which is highly expressed in multiple cancers and critical for metastasis, has not been clearly linked to stemness characteristics in colorectal cancer (CRC). Therefore, this study aimed to investigate the role of TAF7 in CRC stemness.Methods
Differential gene expression and associated signaling pathways were screened using single-cell transcriptomic data from CRC and adjacent normal tissues obtained from the GEO database and validated in CRC cells. A TAF7-knockdown CRC cell line was established to assess the impact of TAF7 on tumor cell stemness. The molecular mechanism of TAF7 in regulating CRC stemness was explored through bioinformatics analysis combined with chromatin immunoprecipitation and dual-luciferase reporter assays and validated by rescue experiments. Finally, a CRC xenograft mouse model was established to examine the effect of targeting TAF7 on tumor cell stemness and epithelial-mesenchymal transition (EMT).Results
Re-analysis of single-cell transcriptomics data identified a TAF7⁺ epithelial cell subpopulation that is highly expressed in CRC and characteristically expresses the stemness marker SOX2. In vitro experiments demonstrated that high TAF7 expression promotes CRC stemness, primarily by enhancing the transcriptional activation of SOX2. Rescue experiments confirmed that targeting the TAF7/SOX2 axis suppresses CRC stemness and EMT. Furthermore, in vivo experiments showed that TAF7 targeting inhibits tumor growth and CRC stemness in mice.Conclusion
Our integrated single-cell transcriptomic and functional analyses reveal that TAF7 promotes CRC stemness and EMT progression via transcriptional activation of the stemness marker SOX2.
Related
- Acquired TRAIL Resistance Promotes Cancer Stemness and Malignant Behavior through CD44-SPHK1-STAT3 Signaling in Colorectal Cancer
- Single-cell RNA Sequencing Analysis Reveals That Targeting PLG–PLGRKT Signaling-mediated Pro-fibrotic Scar-associated Macrophages Ameliorates Liver Fibrosis in Biliary Atresia
- Fibrinogen Alpha Chain (FGA) Associates With Epithelial-Mesenchymal Transition, Stemness, and the USP-Catenin Complex in Colorectal Cancer.
- The SP4–NUPR1–SELM Axis Promotes Glycolytic Reprogramming and Stemness-Associated Phenotypes in Bladder Cancer
- The TGF-β signaling activated by cancer-associated macrophages promotes cancer stemness and Gefitinib resistance in EGFR-mutant non-small-cell lung cancer.
BibTeX
@article{ai2026singlecell,
title = {{Single-cell RNA sequencing reveals that TAF7 promotes colorectal cancer stemness by targeting SOX2.}},
author = {Xiaohui Ai and Yupei Jiang and Xiaoqing Huang and Haitao Ning and Shaojun Wang and Fang Li and Shulin Wu and Jun Mo},
journal = {Biology direct},
year = {2026},
month = jul,
doi = {10.1186/s13062-026-00910-4},
url = {https://europepmc.org/article/MED/42897654},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Single-cell RNA sequencing reveals that TAF7 promotes colorectal cancer stemness by targeting SOX2.
AU - Xiaohui Ai
AU - Yupei Jiang
AU - Xiaoqing Huang
AU - Haitao Ning
AU - Shaojun Wang
AU - Fang Li
AU - Shulin Wu
AU - Jun Mo
PY - 2026
DA - 2026/07/01
JO - Biology direct
DO - 10.1186/s13062-026-00910-4
UR - https://europepmc.org/article/MED/42897654
AB - Background Cancer cell stemness plays a decisive role in tumor metastasis and recurrence. TATA-box binding protein-associated factor 7 (TAF7), which is highly expressed in multiple cancers and critical for metastasis, has not been clearly linked to stemness characteristics in colorectal cancer (CRC). Therefore, this study aimed to investigate the role of TAF7 in CRC stemness.Methods Differential gene expression and associated signaling pathways were screened using single-cell transcriptomic data from CRC and adjacent normal tissues obtained from the GEO database and validated in CRC cells. A TAF7-knockdown CRC cell line was established to assess the impact of TAF7 on tumor cell stemness. The molecular mechanism of TAF7 in regulating CRC stemness was explored through bioinformatics analysis combined with chromatin immunoprecipitation and dual-luciferase reporter assays and validated by rescue experiments. Finally, a CRC xenograft mouse model was established to examine the effect of targeting TAF7 on tumor cell stemness and epithelial-mesenchymal transition (EMT).Results Re-analysis of single-cell transcriptomics data identified a TAF7⁺ epithelial cell subpopulation that is highly expressed in CRC and characteristically expresses the stemness marker SOX2. In vitro experiments demonstrated that high TAF7 expression promotes CRC stemness, primarily by enhancing the transcriptional activation of SOX2. Rescue experiments confirmed that targeting the TAF7/SOX2 axis suppresses CRC stemness and EMT. Furthermore, in vivo experiments showed that TAF7 targeting inhibits tumor growth and CRC stemness in mice.Conclusion Our integrated single-cell transcriptomic and functional analyses reveal that TAF7 promotes CRC stemness and EMT progression via transcriptional activation of the stemness marker SOX2.
SN - 1745-6150
ER -